BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
MYC
,
Response to oxidative stress
,
HIV infection
,
Neuron
,
Laryngoscope
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
alk protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Lymph node biopsies of ALK-positive or negative anaplastic large cell lymphoma patients
Non-small cell lung cancer H3122 cells selected for resistance or sensitivity to crizotinib or X-376
Anaplastic Large Cell Lymphoma and ALK-mediated signaling inhibition by RNAi and compounds
Pediatric neuroblastomas & primitive neuroectodermal tumors treated with decitabine & trichostatin A
Neuroblastoma cell lines with mutations in ALK and MYCN - expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
Real-world ALK Testing Trends in Patients With Advanced Non-Small-Cell Lung Cancer in the United Sta…
Clinical and Molecular Evolution of an ALK-Driven Infant-Type Hemispheric Glioma Treated Sequentiall…
Computational studies of anaplastic lymphoma kinase mutations reveal common mechanisms of oncogenic …
Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Loc…
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery i…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pilot Study of Crizotinib in Relapsed ALK+ Lymphomas
Alectinib in Combination With Bevacizumab in ALK Positive NSCLC
A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastati…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ